Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up
Crossref DOI link: https://doi.org/10.1007/s00270-017-1771-5
Published Online: 2017-09-25
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller-Hülsbeck, Stefan
Keirse, Koen
Zeller, Thomas
Schroë, Herman
Diaz-Cartelle, Juan
Funding for this research was provided by:
Boston Scientific Corporation
License valid from 2017-09-25